StockNews.com Initiates Coverage on Cutera (NASDAQ:CUTR)

Investment analysts at StockNews.com began coverage on shares of Cutera (NASDAQ:CUTR) in a research report issued on Monday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Stock Performance

Shares of NASDAQ CUTR opened at $0.10 on Monday. The firm has a market capitalization of $1.99 million, a price-to-earnings ratio of -0.01 and a beta of 1.36. The stock has a 50 day moving average price of $0.42 and a 200 day moving average price of $0.52. Cutera has a 52-week low of $0.09 and a 52-week high of $3.00.

Institutional Trading of Cutera

An institutional investor recently raised its position in Cutera stock. Geode Capital Management LLC lifted its position in Cutera, Inc. (NASDAQ:CUTR) by 25.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 248,257 shares of the medical device company’s stock after purchasing an additional 50,046 shares during the period. Geode Capital Management LLC owned 1.23% of Cutera worth $88,000 at the end of the most recent quarter. 90.70% of the stock is currently owned by institutional investors and hedge funds.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.